Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Host genetic variants in the pathogenesis of hepatitis C.

Viruses - 1 Dec 2012

Rau Monika, Baur Katharina, Geier Andreas

Abstract excerpt

Direct-acting antiviral drugs (DAAs) are currently replacing antiviral therapy for Hepatitis C infection. Treatment related side effects are even worse and the emergence of resistant viruses must be avoided because of the direct-antiviral action. Altogether it remains a challenge to take treatment decisions in a clinical setting with cost restrictions. Genetic host factors are hereby essential to implement an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 11
Share to ATP-Binding Cassette Transporters

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Host-Pathogen Interactions

Share to Interferons

Share to Interleukins

Share to Pyrophosphatases

Share to Receptors, Calcitriol

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 23342360
DOI: 10.3390/v4123281
PMCID: PMC3528266

Genes

ABCB11
ITPA
VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Host genetic variants in the pathogenesis of hepatitis C.PMID 23342360Read ↗

Pharmacogenetics of hepatitis CSemantic proximity Read ↗

Role of viral and host factors in interferon based therapy of hepatitis C virus infection.Semantic proximity Read ↗

The role of viral and host genetics in natural history and treatment of chronic HCV infection.Semantic proximity Read ↗

Interleukin28B and inosine triphosphatase help to personalize hepatitis C treatment.Semantic proximity Read ↗

Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.Semantic proximity Read ↗

Host genetics.Semantic proximity Read ↗

Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy.Semantic proximity Read ↗

Genomic variation-guided management in chronic hepatitis C.Semantic proximity Read ↗

Host genetics of HCV disease — IL28BSemantic proximity Read ↗

[Genetic polymorphisms as predictors of response to antiviral treatment in chronic hepatitis C virus infection].Semantic proximity Read ↗

Viral and host factors associated with outcomes of hepatitis C virus infectionSemantic proximity Read ↗

Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.